Related Experiment Video

Updated: Sep 28, 2026

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
08:12

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets

Published on: September 6, 2019

Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012)

Susan H Eshleman1, Laura A Guay, Thomas Fleming

  • 1Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA. seshlem@jhmi.edu

Journal of Acquired Immune Deficiency Syndromes (1999)
|November 20, 2002
PubMed

Insights

Virologic factors like HIV-1 subtype A and D did not impact infant survival in Uganda. Further research is needed to understand if HIV-1 subtype influences pediatric HIV clinical outcomes.

Area of Science:

  • Virology
  • Immunology
  • Pediatric Infectious Diseases

Background:

  • Virologic factors, including human immunodeficiency virus type 1 (HIV-1) subtypes, may impact the survival rates of HIV-1-infected infants.
  • Understanding these factors is crucial for improving pediatric HIV management.

Purpose of the Study:

  • To compare the survival rates of Ugandan infants infected with HIV-1 subtype A versus subtype D.
  • To investigate the influence of HIV-1 subtype on infant survival within the context of the HIVNET 012 trial.

Main Methods:

  • Phylogenetic analysis of HIV-1 protease and reverse transcriptase sequences was used to determine subtypes.
  • Data were collected from infants born to mothers enrolled in the Ugandan HIVNET 012 clinical trial.

Main Results:

  • No statistically significant association was found between HIV-1 subtype (A vs. D) and infant survival in the studied cohort.
  • Infant HIV-1 infection status was confirmed at 6 to 8 weeks of age.

Conclusions:

  • HIV-1 subtype A and D do not appear to influence infant survival in this Ugandan cohort.
  • Additional research is necessary to determine if HIV-1 subtype impacts clinical outcomes in pediatric HIV-1 infection.

More Related Videos

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...